Literature DB >> 26297240

CaMKII-dependent myofilament Ca2+ desensitization contributes to the frequency-dependent acceleration of relaxation.

Arnaud Guilbert1, Hyun Joung Lim1, Jun Cheng2, Yanggan Wang3.   

Abstract

BACKGROUND: Previous studies suggest that CaMKII activity is required for frequency-dependent acceleration of relaxation (FDAR) in ventricular myocytes. We propose that the underlying mechanism involves CaMKII-dependent regulation of myofilament Ca(2+) sensitivity. METHODS AND
RESULTS: Cardiac function was measured in mice using murine echo machine. [Ca(2+)]i and sarcomere length were measured by IonOptix Ca(2+) image system. Increasing pacing rate from 0.5 to 4 Hz in left ventricular myocytes induced frequency-dependent myofilament Ca(2+) desensitization (FDMCD) and FDAR. Acute inhibition of PKA or PKC had no effect, whereas CaMKII inhibition abolished both FDMCD and FDAR. Co-immunoprecipitation of CaMKII and troponin I (TnI) has been detected and CaMKII inhibition significantly reduced serine residue phosphorylation of TnI. Finally, chronic inhibition of CaMKII in vivo reduced TnI phosphorylation and abolished both FDAR and FDMCD, leading to impaired diastolic function.
CONCLUSIONS: Our results suggest that CaMKII-dependent TnI phosphorylation is involved in FDMCD and the consequent FDAR and that CaMKII inhibition removes this mechanism and thus induces diastolic dysfunction.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CaMKII; Contraction; Myocytes; Myofilament Ca(2+) sensitivity; Relaxation

Mesh:

Substances:

Year:  2015        PMID: 26297240      PMCID: PMC4662934          DOI: 10.1016/j.ceca.2015.08.001

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  39 in total

1.  Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.

Authors:  B Pieske; L S Maier; D M Bers; G Hasenfuss
Journal:  Circ Res       Date:  1999-07-09       Impact factor: 17.367

2.  The effect of myosin regulatory light chain phosphorylation on the frequency-dependent regulation of cardiac function.

Authors:  Fernando A L Dias; Lori A Walker; Grace M Arteaga; John S Walker; Kalpana Vijayan; James R Peña; Yunbo Ke; Rosalvo T H Fogaca; Atsushi Sanbe; Jeffrey Robbins; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2006-06-30       Impact factor: 5.000

3.  Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity.

Authors:  Kenneth D Varian; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-05       Impact factor: 4.733

4.  Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.

Authors:  Jerald Curran; Mark J Hinton; Eduardo Ríos; Donald M Bers; Thomas R Shannon
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

5.  The cAMP binding protein Epac regulates cardiac myofilament function.

Authors:  Olivier Cazorla; Alexandre Lucas; Florence Poirier; Alain Lacampagne; Frank Lezoualc'h
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

6.  Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure.

Authors:  Rashad J Belin; Marius P Sumandea; Tomoyoshi Kobayashi; Lori A Walker; Veronica L Rundell; Dalia Urboniene; Milana Yuzhakova; Stuart H Ruch; David L Geenen; R John Solaro; Pieter P de Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-30       Impact factor: 4.733

7.  CaMKII inhibition targeted to the sarcoplasmic reticulum inhibits frequency-dependent acceleration of relaxation and Ca2+ current facilitation.

Authors:  Eckard Picht; Jaime DeSantiago; Sabine Huke; Marcia A Kaetzel; John R Dedman; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2006-10-17       Impact factor: 5.000

Review 8.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

9.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

10.  Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII.

Authors:  Sabine Huke; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2006-12-21       Impact factor: 5.000

View more
  5 in total

1.  Oxidized CaMKII (Ca2+/Calmodulin-Dependent Protein Kinase II) Is Essential for Ventricular Arrhythmia in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Qiongling Wang; Ann P Quick; Shuyi Cao; Julia Reynolds; David Y Chiang; David Beavers; Na Li; Guoliang Wang; George G Rodney; Mark E Anderson; Xander H T Wehrens
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-04

2.  Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction.

Authors:  Zhebo Liu; Bo Tao; Suzhen Fan; Shengyu Cui; Yong Pu; Liqiang Qiu; Hao Xia; Lin Xu
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

3.  Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1.

Authors:  Rong Zhang; Yi Xu; Huifang Niu; Ting Tao; Tao Ban; Linyao Zheng; Jing Ai
Journal:  J Cell Mol Med       Date:  2018-08-17       Impact factor: 5.310

4.  SERCA is critical to control the Bowditch effect in the heart.

Authors:  Darío Balcazar; Victoria Regge; Manuela Santalla; Heiko Meyer; Achim Paululat; Alicia Mattiazzi; Paola Ferrero
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

5.  Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats.

Authors:  Lorna J Daniels; Rachel S Wallace; Olivia M Nicholson; Genevieve A Wilson; Fiona J McDonald; Peter P Jones; J Chris Baldi; Regis R Lamberts; Jeffrey R Erickson
Journal:  Cardiovasc Diabetol       Date:  2018-06-14       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.